STENDRA (AVANAFIL) TABLETS Trademark

Trademark Overview


On Saturday, March 18, 2017, a trademark application was filed for STENDRA (AVANAFIL) TABLETS with the United States Patent and Trademark Office. The USPTO has given the STENDRA (AVANAFIL) TABLETS trademark a serial number of 87376446. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Tuesday, January 29, 2019. This trademark is owned by Metuchen Pharmaceuticals LLC. The STENDRA (AVANAFIL) TABLETS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals for the treatment of erectile dysfunction and sexual dysfunctions and disorders, and for the maintenance of sexual health, for use in the treatment and prevention of incontinence, for treatment of prostate and urinary tract diseases and disorders, for treatment of cardiovascular or endothelial disease, disorders or dysfunction, for treatment of neurodegenerative diseases, and for memory enhancement
stendra (avanafil) tablets

General Information


Serial Number87376446
Word MarkSTENDRA (AVANAFIL) TABLETS
Filing DateSaturday, March 18, 2017
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateTuesday, January 29, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, September 5, 2017

Trademark Statements


In Another Form StatementThe mark was first used anywhere in a different form other than that sought to be registered at least as early as 12/27/2013
In Another Form StatementThe mark was first used in commerce in a different form other than that sought to be registered at least as early as 12/27/2013
Indication of Colors claimedThe color(s) silver, yellow, orange, copper and grey is/are claimed as a feature of the mark.
Disclaimer with Predetermined Text"AVANAFIL TABLETS"
Description of MarkThe mark consists of the stylized term "STENDRA" in silver with the appearance of brushed metal. The term "STENDRA" is partially outlined in copper and yellow and includes partial shadowing in grey. A split curved line design in the colors orange, copper and silver appears to the right of the term "STENDRA" with radiating lines in various shades of yellow, orange and copper appearing behind the term "STENDRA". The silver wording "(AVANAFIL) TABLETS" appears underneath the term "STENDRA".
Goods and ServicesPharmaceuticals for the treatment of erectile dysfunction and sexual dysfunctions and disorders, and for the maintenance of sexual health, for use in the treatment and prevention of incontinence, for treatment of prostate and urinary tract diseases and disorders, for treatment of cardiovascular or endothelial disease, disorders or dysfunction, for treatment of neurodegenerative diseases, and for memory enhancement

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, March 23, 2017
Primary Code005
First Use Anywhere DateSunday, March 25, 2018
First Use In Commerce DateSunday, March 25, 2018

Trademark Owner History


Party NameMetuchen Pharmaceuticals LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressCranford, NJ 07016

Party NameMetuchen Pharmaceuticals LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressCranford, NJ 07016

Trademark Events


Event DateEvent Description
Wednesday, January 30, 2019ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Tuesday, January 29, 2019ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Tuesday, July 3, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, July 3, 2018NON-FINAL ACTION E-MAILED
Tuesday, July 3, 2018SU - NON-FINAL ACTION - WRITTEN
Thursday, April 12, 2018STATEMENT OF USE PROCESSING COMPLETE
Sunday, March 25, 2018USE AMENDMENT FILED
Thursday, April 12, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Sunday, March 25, 2018TEAS STATEMENT OF USE RECEIVED
Tuesday, October 31, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 5, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 5, 2017PUBLISHED FOR OPPOSITION
Wednesday, August 16, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, July 24, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, July 24, 2017EXAMINER'S AMENDMENT ENTERED
Monday, July 24, 2017NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, July 24, 2017EXAMINERS AMENDMENT E-MAILED
Monday, July 24, 2017EXAMINERS AMENDMENT -WRITTEN
Saturday, July 22, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, July 22, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, July 22, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, June 28, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, June 28, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, June 28, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, June 27, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, June 27, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, June 27, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, June 23, 2017NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Friday, June 23, 2017EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Friday, June 23, 2017COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
Friday, June 23, 2017EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Monday, June 12, 2017ASSIGNED TO EXAMINER
Friday, March 24, 2017NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, March 23, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Wednesday, March 22, 2017NEW APPLICATION ENTERED IN TRAM